Abstract:Necroptosis is a caspase-independent modality of cell death implicated in many inflammatory pathologies. The execution of this pathway requires the formation of a cytosolic platform that comprises RIPK1 and RIPK3 which, in turn, mediates the phosphorylation of the pseudokinase MLKL (S345 in mouse). The activation of this executioner is followed by its oligomerisation and accumulation at the plasma-membrane where it leads to cell death via plasma-membrane destabilisation and consequent permeabilisation. While the biochemical and cellular characterisation of these events have been amply investigated, the study of necroptosis involvement in vivo in animal models is currently limited to the use of Mlkl −/− or Ripk3 −/− mice. Yet, even in many of the models in which the involvement of necroptosis in disease aetiology has been genetically demonstrated, the fundamental in vivo characterisation regarding the question as to which tissue(s) and specific cell type(s) therein is/are affected by the pathogenic necroptotic death are missing. Here, we describe and validate an immunohistochemistry and immunofluorescence-based method to reliably detect the phosphorylation of mouse MLKL at serine 345 (pMLKL-S345). We first validate the method using tissues derived from mice in which Caspase-8 (Casp8) or FADD are specifically deleted from keratinocytes, or intestinal epithelial cells, respectively. We next demonstrate the presence of necroptotic activation in the lungs of SARS-CoV-infected mice and in the skin and spleen of mice bearing a Sharpin inactivating mutation. Finally, we exclude necroptosis occurrence in the intestines of mice subjected to TNF-induced septic shock. Importantly, by directly comparing the staining of pMLKL-345 with that of cleaved Caspase-3 staining in some of these models, we identify spatio-temporal and functional differences between necroptosis and apoptosis supporting a role of RIPK3 in inflammation independently of MLKL versus the role of RIPK3 in activation of necroptosis.

Adrenalectomy for advanced breast cancer: a reappraisal.

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

The MLKL Channel in Necroptosis is an Octamer Formed by Tetramers in a Dyadic Process.

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis

Motor skills bibliography: 33. Psychological Abstracts, 1958, Volume 32, second half.

Exercise‐Based Cardiac Rehabilitation for Very Old Patients (≥75 Years): FOCUS ON PHYSICAL FUNCTION

Pregnancy outcome after suicide attempt by drug use: a Danish population‐based study

The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling

Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

[Interhemispheric differences and the interaction of the hemispheres].

Ureide ring scission of phenobarbital by sodium borohydride.

Cytoplasmic microtubular dynamics and chromatin organization during mammalian oogenesis and oocyte maturation.

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Necrosome core machinery: MLKL

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation

The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo

Necroptosis executioner MLKL plays pivotal roles in agonist-induced platelet prothrombotic responses and lytic cell death in a temporal order

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

Structural Insights into RIP3-Mediated Necroptotic Signaling